tiprankstipranks

12222022 top21 - New Portfolio

613D487C

12222022 top21
Individual Investor
Ranked #296,532 out of 732,075 TipRanks' Investors
Success Rate
46%
177 out of 384
profitable transactions
Average Return
7.48%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 4.66%
6-Month Return▲ 57.12%
12-Month Return▲ 21.47%
YTD Return▲ 27.27%
Total Return▲ 54.33%

Best Trade

Opened at
Closed at
Gain▲ 418.52%

Bio

Financial advisor for 45 years.?

Performance

22.76%0-22.76%
▼ 6.45%
▼ 2.17%
▼ 6.04%
Oct 2023
▲ 9.22%
▲ 9.13%
▲ 7.31%
Nov 2023
▲ 5.14%
▲ 4.57%
▲ 22.76%
Dec 2023
▼ 1.87%
▲ 1.59%
▲ 6.59%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 22.61%
Feb 2024
▲ 5.05%
▲ 3.27%
▲ 5.80%
Mar 2024
▼ 12.40%
▼ 4.03%
▼ 14.11%
Apr 2024
▲ 6.24%
▲ 1.85%
▲ 7.18%
May 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 6.45%▼ 2.17%▼ 6.04%
▲ 9.22%▲ 9.13%▲ 7.31%
▲ 5.14%▲ 4.57%▲ 22.76%
▼ 1.87%▲ 1.59%▲ 6.59%
▲ 14.08%▲ 5.22%▲ 22.61%
▲ 5.05%▲ 3.27%▲ 5.80%
▼ 12.40%▼ 4.03%▼ 14.11%
▲ 6.24%▲ 1.85%▲ 7.18%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
hrcr6qj1ox
hrcr6qj1ox
hrcr6qj1ox
hrcr6qj1ox
hrcr6qj1ox
hrcr6qj1ox
hrcr6qj1ox
u57cupqr6
u57cupqr6
u57cupqr6
u57cupqr6
u57cupqr6
u57cupqr6
u57cupqr6
kyjj105ev9c
kyjj105ev9c
kyjj105ev9c
kyjj105ev9c
kyjj105ev9c
kyjj105ev9c
kyjj105ev9c
b5wf0bzcxq
b5wf0bzcxq
b5wf0bzcxq
b5wf0bzcxq
b5wf0bzcxq
b5wf0bzcxq
b5wf0bzcxq
nhz9146tv4e
nhz9146tv4e
nhz9146tv4e
nhz9146tv4e
nhz9146tv4e
nhz9146tv4e
nhz9146tv4e
gtwti55jhgp
gtwti55jhgp
gtwti55jhgp
gtwti55jhgp
gtwti55jhgp
gtwti55jhgp
gtwti55jhgp
09s7ptwf407m
09s7ptwf407m
09s7ptwf407m
09s7ptwf407m
09s7ptwf407m
09s7ptwf407m
09s7ptwf407m
d5azdyv20ju
d5azdyv20ju
d5azdyv20ju
d5azdyv20ju
d5azdyv20ju
d5azdyv20ju
d5azdyv20ju
r5vo68vkkjn
r5vo68vkkjn
r5vo68vkkjn
r5vo68vkkjn
r5vo68vkkjn
r5vo68vkkjn
r5vo68vkkjn
av0tnehope
av0tnehope
av0tnehope
av0tnehope
av0tnehope
av0tnehope
av0tnehope
To view investors' portfolios
Sign Up For Free
Permrock Royalty
▲ 3.77%
2
Close
Mar 05, 2024
Autolus Therapeutics
1.56%
▲ 37.86%
4
Open
Feb 27, 2024
Editas Medicine
1.56%
▼ 27.22%
4
Open
Feb 27, 2024
Can-Fite BioPharma
▼ 20.51%
6
Close
Feb 27, 2024
Gritstone Oncology
▼ 9.80%
4
Close
Feb 27, 2024
Dianthus Therapeutics
▼ 15.24%
4
Close
Feb 27, 2024
Stoke Therapeutics
1.56%
▲ 5.91%
5
Open
Feb 27, 2024
Sutro Biopharma
▼ 19.61%
6
Close
Feb 27, 2024
Syros Pharmaceuticals
▲ 65.72%
4
Close
Feb 27, 2024
Jasper Therapeutics
▲ 6.90%
3
Close
Feb 27, 2024
NGM Biopharmaceuticals
▲ 2.11%
4
Close
Feb 27, 2024
Mersana Therapeutics
1.56%
▲ 20.29%
4
Open
Feb 27, 2024
Intellia Therapeutics
▼ 1.62%
3
Close
Feb 27, 2024
Xeris Pharmaceuticals
▲ 29.40%
6
Close
Feb 27, 2024
Sonnet BioTherapeutics Holdings
1.56%
▲ 9.37%
3
Open
Feb 27, 2024
Landos Biopharma
1.56%
▲ 249.06%
1
Open
Feb 27, 2024
Akoya Biosciences
1.56%
▼ 32.71%
4
Open
Feb 27, 2024
Heron Therapeutics
▲ 66.06%
2
Close
Feb 27, 2024
Syndax Pharmaceuticals
▲ 30.71%
3
Close
Feb 27, 2024
Akero Therapeutics
▼ 6.90%
3
Close
Feb 27, 2024